Hepatitis B control by 2012 in the WHO Western Pacific Region:

Rani, Manju; Yang, Baoping; Nesbit, Richard

doi:10.2471/blt.08.059220

Cited by 57 publications

(57 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite a WHO recommendation for universal infant immunization since 1992, introduction of a national universal vaccination program was slow in most of the low/low-to-middle income countries: Cambodia, China, the Lao People's Democratic Republic, Philippines, and Vietnam [73]. In China, HBV vaccination was integrated into the EPI in 2001, though not made a completely free service until 2005 [74].…”

Section: Western Pacificmentioning

confidence: 98%

Global Epidemiology of Hepatitis B Virus (HBV) Infection

Papastergiou

Lombardi

MacDonald

et al. 2015

Curr Hepatology Rep

View full text Add to dashboard Cite

Infection with hepatitis B virus (HBV) remains a top health priority worldwide and a devastating cause of morbidity and mortality accounting for more than 600,000 deaths in 2013. It is mainly transmitted through percutaneous or mucosal contact with infected blood or other body fluids. In high-endemic settings, the commonest route of transmission is from infected mothers to neonates, whereas in areas of low endemicity the infection is mostly acquired during adolescence and early adulthood through high-risk behaviors. More than 350 million are chronically infected with HBV, ranging from <0.5 % in areas of low endemicity to above 8 % in highly-endemic countries, with hyperendemic foci in South-East Asia and Western Pacific Regions. Expansion of national immunization programs with >80 % coverage globally has resulted in a steady decline in the prevalence of HBV. However, there are remaining threats to the successful eradication of HBV worldwide. We review available data on global epidemiology of HBV infection, also focusing on transmission modes by region and specific preventative measures instituted.

show abstract

Section: Western Pacificmentioning

confidence: 98%

Global Epidemiology of Hepatitis B Virus (HBV) Infection

Papastergiou

Lombardi

MacDonald

et al. 2015

Curr Hepatology Rep

View full text Add to dashboard Cite

show abstract

“…1,6,8,16 Thus, minimum number of 240 subjects was recruited for the study. A multistage sampling method was adopted for the study.…”

Section: -Bymentioning

confidence: 99%

“…4,5 HBV infection is a vaccine-preventable disease and HepB vaccine has been available for decades in developed countries. 5,6 Northern Nigeria has one of the lowest rates of immunization coverage in the world. 7 Information on the prevalence of HBV infection in certain parts of Northern Nigeria such as the study area is scarce.…”

Section: Introductionmentioning

confidence: 99%

Seroprevalence of hepatitis B Surface antigen among apparently healthy primary school pupils in Batagarawa Local Government area of Katsina State, Nigeria

Habibu¹,

Belonwu²,

Ibrahim³

2017

Nig. J. Paed.

View full text Add to dashboard Cite

“…The WPR of WHO has led the way in hepatitis B control as the first Region to establish a time-bound goal to reduce childhood chronic infection rates (36). Through hepatitis B immunization 30 out of 37 countries and areas have reached the 2012 milestone of reducing the rate of chronic hepatitis B infection among 5-year-old children to <2% (37).…”

Section: Box 1 Liver Cancer Attributable To Hepatitis B and C Virusementioning

confidence: 99%

Prevention of infection-related cancers in the WHO Western Pacific Region

Shin

Woo

et al. 2015

Jpn. J. Clin. Oncol.

View full text Add to dashboard Cite

A considerable number of infectious agents have been classified as human carcinogens Group 1 by the International Agency for Research on Cancer. Major infection-related cancers such as cancers of nasopharynx (53%), stomach (60%) and liver (63%) occur in the World Health Organization Western Pacific Region. Many infection-related cancers are preventable, particularly those associated with human papilloma virus, Helicobacter pylori, human immunodeficiency virus-I, hepatitis B virus and hepatitis C virus and liver flukes. Mongolia shows the highest prevalence of hepatitis B virus and hepatitis C virus, and China shows the highest prevalence of Helicobacter pylori. Chronic infection is attributable for 17-28% of overall cancer incidence or mortality in China, Japan and Korea. Through infant immunization for hepatitis B, 30 of 37 countries and areas in the Western Pacific Region have reached the 2012 milestone of chronic hepatitis B virus infection prevalence of <2% in 5-year-old children and countries and areas of the region are now striving toward reaching the regional goal of <1% by 2017. Human papilloma virus immunization program is implemented either by government funding or, in some low-income countries, by public and private sector organizations. Cervical cancer screening via visual inspection with acetic acid or Pap smear is available in many Western Pacific Region Member States. More efforts are needed to implement new World Health Organization guide to vaccinate 9-to 13-year-old girls with two doses of human papilloma virus vaccine, and use human papilloma virus tests to screen women to prevent and control cervical cancer including guaranteed monitoring and appropriate follow-up for abnormal results.

show abstract

Hepatitis B control by 2012 in the WHO Western Pacific Region:

Cited by 57 publications

References 16 publications

Global Epidemiology of Hepatitis B Virus (HBV) Infection

Global Epidemiology of Hepatitis B Virus (HBV) Infection

Seroprevalence of hepatitis B Surface antigen among apparently healthy primary school pupils in Batagarawa Local Government area of Katsina State, Nigeria

Prevention of infection-related cancers in the WHO Western Pacific Region

Contact Info

Product

Resources

About